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Abstract
Differential, histochemical and immunohistochemical changes were observed in hepatocytes
from immediately to 7 days after isoflurane or sevoflurane exposure (at H 0 to on Day 7) to study
the process of development and recovery in anesthetic-induced hepatic injury. A total of 570
7-week-old male Sprague-Dawley rats with or without phenobarbital treatment were exposed
to isoflurane or sevoflurane in 100%, 21%, or 10% oxygen, or to 10% oxygen alone for 2h.
In phenobarbital-treated rats, hepatocytes both with and without anesthetic exposure markedly
changed in 10% oxygen at H 0. Glycogen and ribosomal ribonucleic acid (rRNA) disappeared at
H 0 and at H 6, respectively, and at H 6, AST levels in the blood rose. From H 6 to Day 1, necrosis
developed more markedly and widely in zone 3 hepatocytes exposed to anesthetics in 10% oxygen
than in those exposed to oxygen alone. All degenerated tissues had returned to normal levels by
day 7. Recovery of the hepatolobular structure may be attributed to rearrangement of remaining
hepatocytes in the portal vein area. Both the disappearance of glycogen and rRNA and the in-
crease in blood AST levels after exposure to isoflurane or sevoflurane are considered to be factors
contributing to the induction of necrosis around the central vein. The grade of isoflurane-induced
hepatic injury was found to be significantly higher than that of sevoflurane.
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Diﬀerential, histochemical and immunohistochemical changes were observed in hepatocytes from immediately to 7 days after isoﬂurane or sevoﬂurane exposure (at H 0 to on Day 7) to study the process of development and recovery in anesthetic-induced hepatic injury. A total of 570 7-week-old male Sprague-Dawley rats with or without phenobarbital treatment were exposed to isoﬂurane or sevoﬂurane in 100 , 21 , or 10  oxygen, or to 10  oxygen alone for 2 h. In phenobarbital-
treated rats, hepatocytes both with and without anesthetic exposure markedly changed in 10 oxygen at H 0. Glycogen and ribosomal ribonucleic acid (rRNA)disappeared at H 0 and at H 6,
respectively, and at H 6, AST levels in the blood rose. From H 6 to Day 1, necrosis developed more markedly and widely in zone 3 hepatocytes exposed to anesthetics in 10  oxygen than in those exposed to oxygen alone. All degenerated tissues had returned to normal levels by day 7. Recovery of the hepatolobular structure may be attributed to rearrangement of remaining hepatocytes in the portal vein area. Both the disappearance of glycogen and rRNA and the increase in blood AST levels after exposure to isoﬂurane or sevoﬂurane are considered to be factors contributing to the induction of necrosis around the central vein. The grade of isoﬂurane-induced hepatic injury was found to be significantly higher than that of sevoﬂurane.
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H alothane-related hepatic injury has been described in many reports［1, 2］, and the products of halothane biotransformation have been suggested to induce hepatic injury［3, 4］. Approximately 20 ,
2.0 , and 0.2  of inhaled halothane, enﬂurane, and isoﬂurane, respectively, is metabolized, and harmful substances are produced in vivo［5］. Sevoﬂurane is also metabolized in vivo, but it does not produce reactive metabolites［6］. Despite these variations, sevoﬂurane,
isoﬂurane and enﬂurane all reportedly cause hepatic injury accompanied by centrilobular necrosis［7-13］, though the etiology of the hepatic injury induced by these anes-
thetics has not yet been clariﬁed.
There have been a few reports of histochemical and immunohistochemical observations of intrahepatocellular changes after exposure to halothane and isoﬂurane［14-
16］. In the current study, the authors histochemically and immunohistochemically observed hepatic changes using the same methods as those used previously［15,
17］to study the diﬀerences in the occurrence of early-
stage hepatic injury and time-course changes (including development of and recovery from hepatic injury)in the
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rat liver at speciﬁc sites from immediately to 7 days after exposures to isoﬂurane(metabolized in vivo to produce harmful substances)and sevoﬂurane(metabolized, but not producing harmful substances).
Materials and Methods
 
All animal experiments were performed according to the Guidelines for Animal Experiments of the Okayama University Medical School.
The materials and reagents used in this study were as follows:7-week-old male Sprague-
Dawley (SD) rats (Clea Japan Inc., Osaka, Japan);
sevoﬂurane and isoﬂurane(Dainippon Pharmaceutical Co.,
Osaka, Japan);phenobarbital sodium and pentobarbital sodium (Tokyo Chemical Industry Co., Ltd., Tokyo,
Japan);Mayer hemalum solution, and Schiﬀ’s reagent
(PAS)(Merck, Darmstadt, Germany);4  paraformal-
dehyde and 1  eosin Y solution(Muto Pure Chemicals Co., Ltd., Tokyo, Japan);anti-macrophage mouse monoclonal antibody (ED 1) (Serotec Ltd., Oxford,
England);diastase(αamylase)and ribonuclease I(Sigma-
Aldrich chemie gmbh, Sreinheim, Germany);5-bromo-
2’-deoxyuridine (BrdU), anti-BrdU mouse monoclonal antibody, anti-single-stranded DNA (ssDNA) rabbit polyclonal antibody, anti-mouse or anti-rabbit immunog-
lobulins conjugated to peroxidase-labeled dextran polymer
(EnVision＋??・Peroxidase), and 3,3’-diaminobenzidine
(DAB) substrate kit (Dako Japan Co., Ltd., Kyoto,
Japan), and IATAROZYME TA-Lq (RM 163-K)
(Iatron Laboratories Inc., Tokyo, Japan)as a reagent for analyzing aspartate aminotransferase(AST).
Reagents of the best quality were purchased in addi-
tion to those mentioned above.
As shown in Fig. 1, male SD rats were divided into 2 groups:
nontreated healthy rats (N-group)and rats given water containing 0.1  phenobarbital solution (PB)ad libitum for 5 days (PB-group)before the experiment［15, 17］.
The experiment was carried out as follows:Rats from both groups were separately exposed to 1.5  isoﬂurane and 2.0  sevoﬂurane(approximately 1 minimum alveolar concentration［MAC］of isoﬂurane［18］and sevoﬂurane
［19］), respectively, in 100 , 21 , or 10  oxygen,
or 10  oxygen alone without anesthetics for 2 h. Air was used for 21  oxygen, and air and nitrogen were mixed at a 1:1 ratio with an anesthesia apparatus(Model CK-70, Acoma Co., Tokyo, Japan) to create gas
 
containing 10  oxygen. The ﬂow-volume of oxygen gas of 3 diﬀerent concentrations (100 , 21 , and 10 )
was set at 4 L/min with the anesthesia apparatus.
Concentrations were adjusted to 1.5  and 2.0  for isoﬂurane (Penlon Ltd., Abingdon, UK) and for sevoﬂurane(Akoma Co., Tokyo, Japan), respectively,
with vaporizers. Rats in a polyethylene container(20×
30×10 cm)were exposed to isoﬂurane or sevoﬂurane through a tube connected to the vaporizer.
The livers of 5 rats from each exposure group were collected at 0 h (immediately), 3 h, 6 h, 12 h, 1 day,
2 days, 3 days, and 7 days after the isoﬂurane or sevoﬂurane exposure(at H 0-12, on Days 1-7). Five rats each were used under 114 diﬀerent conditions, i.e., 8 diﬀerent collection times by 3 diﬀerent 2-h exposures(in 100 , 21 , or 10  oxygen)to 2 diﬀerent anesthetics,
or in 10  oxygen alone in 2 groups, plus the group of rats treated with PB alone, and 1 control (untreated)
group(Fig. 1).
The collected livers were histochemically and immuno-
histochemically studied for general cell structure, glyco-
gen, apoptosis, ribosomal ribonucleic acid(rRNA)gran-
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Fig. 1  Grouping of rats and sample-collection time. The total number of conditions and rats examined were 114 conditions and 570 rats (5 rats each were used under each condition). PB-group, rats pretreated with 0.1% phenobarbital solution (PB)ad libitum for 5 days. N-group, rats without PB pretreated. PB alone-group, rats treated with PB alone. Control group, nontreated healthy rats. H 0-
12 and D 1-7 show the sample-collection time at 0(immediately)-12 h and 1-7 days after each anesthetic exposure.
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ules in the cells, cell proliferation, and inﬁltrated cells.
When the livers were collected, 5 specimens, each taken under diﬀerent test conditions, underwent a median inci-
sion in the abdomen under the anesthesia with pentobar-
bital sodium. Next, 3 ml of the blood was collected in a heparinized glass syringe from the left ventricle to deter-
mine the AST measurement.
The liver was excised after perfusion through the portal vein with 4  paraformaldehyde(4 PFA), cut into pieces in 2-3 mm thick, and ﬁxed in 4 ice-cooled PFA. After being dehydrated with alcohol according to routine procedures, the sections were em-
bedded in paraﬃn, cut into pieces 5μm thick, stained with H-E, PAS, and methylgreen pyronin(MGP), and examined by diastase(αamylase)and ribonuclease digest tests.
Arbitrarily selected paraﬃn-removed sections were immersed in 3  H?O?/MtOH at room temperature for 10 min to dispose of the intrinsic peroxidase, then immersed in trypsin solution (1 mg trypsin/ml 0.1 M PBS)at 37°C for 30 min to identify the inﬁltrated and apoptotic cells. Next, ED 1 and anti-ssDNA antibodies
(rabbit)were used as the primary antibodies to identify inﬁltrated and apoptotic cells. EnVision＋??・peroxidase
(mouse or rabbit)were used as the secondary antibodies to make the target cells emit colors with a DAB substrate kit. The spleen and small intestine were used to test for positive reactions to macrophage(ED 1)and apoptosis
(ssDNA).
To study hepatocellular proliferation, BrdU (50 mg/
kg)dissolved in 1 ml of PBS was intraperitoneally ad-
ministered 2 h before liver resection. The rats underwent median abdominal incision under pentobarbital anesthesia.
The liver was then excised, immersed in 70  ice-cooled ethanol, dehydrated, and embedded in paraﬃn. After the liver was cut into 5-μm sections, the slide glasses were immersed in 3  H?O?/MtOH. Anti-BrdU mouse monoclonal antibody was used for the primary antibody,
and EnVision＋??・peroxidase (mouse)were used for the secondary antibodies. The remaining one-third of the liver was used for the BrdU-intake test(proliferation)by the methods of Higgins and Anderson［20］.
AST values from H 0 to Day 7 after exposure to isoﬂurane or sevoﬂurane were analyzed in the serum collected from 5 rats by the
 
statistical tests described below to compare them with the values of the control group and with values collected at diﬀerent times. The data were analyzed by a Dunnett’s test to compare with control values to get a signiﬁcant diﬀerence, and by a Tukey’s honestly signiﬁcant diﬀerence test to compare among collection times. Values of P＜0.05 were assumed to be signiﬁcant.
The area of the lobule negatively stained with PAS
［PAS(－)］is expressed as a percentage of the liver lobule. The length of the lobule from the central vein
(CV)to the portal vein(PV)was measured as a, and that of the PAS(－)area from the CV to PV as b to calculate the PAS(－)area as a percentage of the lobule(y)as follows:y( )＝b/a×100. Straight  lines of the sinusoid running from the PV to the CV were selected to measure the lengths of a and b. At each collection time,
a and b were measured in the 25 samples that had been taken from 5 diﬀerent regions in the lobules of 5 rats.
The mean percentage of the PAS(－) area (Y) was obtained from these 25 (y) samples (Y:mean±SD).
Each value of Y was analyzed by the same statistical tests described above to compare it with the H 0 values and to compare among values at diﬀerent collection times.
Results
 
As shown in Fig. 2, the AST values (mean±SD) of rats in the control and PB-pretreated alone groups were 46.0±5.2 U and 47.4±6.9 U, respectively. The AST values in both the PB-and the N-groups after isoﬂurane or sevoﬂurane exposure under 100  and 21  oxygen, or exposure to 10  oxygen alone, diﬀered little from those of the control group(data not shown).
In the PB-group, the AST values diﬀered from those of the control group after each anesthetic exposure under 10  oxygen. From H 3 after each anesthetic exposure under 10  oxygen, the AST values began to increase and at H 6 signiﬁcantly increased(isoﬂurane:91.6±13.5 U and sevoﬂurane;84.4±8.3 U)when compared with those of the control group (P＜0.01), reaching the highest value at H 12 (isoﬂurane;98.6±10.0 U and sevoﬂurane;91.2±11.0 U)(P＜0.01). On Day 1, the AST values began to decrease, returning to normal levels by Day 3. In the N-group, the AST values were slightly higher than those of the control group from H 3 to Day 1, reached a peak (isoﬂurane: 68.0± 12.6 U,
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 sevoﬂurane:62.2±12.2 U)at H 12, and then returned to normal levels on Day 2 after each anesthetic exposure.
From H 6 to Day 1, AST levels were signiﬁcantly higher in isoﬂurane-exposed cells than in those exposed to sevoﬂurane (P＜0.05), and there were signiﬁcant diﬀerences among the values between the BP-and the N-groups after exposure to each anesthetic(P＜0.01).
Figs. 3, 4, and 5 show the changes caused by PAS, MGP, and H-E stainings from the control to Day 1. Fig. 6 shows the statistical analyses of changes in the PAS(－)area under 10  oxygen concentration from H 0 to Day 7.
An image of the liver tissues in control rats is shown in Figs. 3a, 4a, and 5a. PAS-positive substances(Fig.
3a)and MGP-positive granules in the cells(Fig. 4a)were observed evenly in the area from the CV to the PV. The photos in the right lower portions of Figs. 3a and 4a show the results of the diastase or ribonuclease digest test, and that the positively stained granule with PAS and MGP is that of glycogen or rRNA. Figure 5a shows an image of the liver tissues stained with H-E that is almost identical to that of rats pretreated with PB alone, as seen in the control rats (Figs. 3e, 4e, and 5e).
In the N-group, no histological changes were seen in any of the hepatocytes exposed to the anesthetics for 2 h under 100  or 21  oxygen compared with the control images. However, after 2 h exposure to isoﬂurane or sevoﬂurane in 10  oxygen, PAS staining slightly de-
creased to approximately 35 of the area from the CV to the PV in response to both of these anesthetic exposures,
respectively, decreasing signiﬁcantly from H 0 to H 6,
then returning to the control level at H 12(Fig. 6).
In the PB-group, there were no changes in PAS staining under 100  oxygen as compared with the control group. However, PAS staining decreased to approximately 30-35  of the area from the CV to the PV after 2 h of exposure to isoﬂurane or sevoﬂurane in 21 oxygen at H 0, but then increased again in a manner similar to that of the N-group in 10  oxygen alone.
Changes in cell structure could not be identiﬁed by H-E or MGP staining in the area where the PAS staining decreased.
Marked changes were observed in the cells exposed to isoﬂurane or sevoﬂurane for 2 h in 10  oxygen. By PAS staining, after isoﬂurane exposure, approximately 36.5  of the area from the CV to the PV was revealed
 
Fig.2  Time-course changes in serum aspartate aminotransferase(AST)after anesthetic exposure under 10%oxygen. Each collecting value was the mean±SD of 5 rats’values.◎, Control group(Control);◇, PB alone group(PB-alone);●, Isoﬂurane exposure in the PB-group;
■, Sevoﬂurane exposure in the PB-group;○, Isoﬂurane exposure in the N-group;□, Sevoﬂurane exposure in the N-group;★, signiﬁcantly higher than that of the control(P＜0.01);＊, signiﬁcant diﬀerences among the values after isoﬂurane and sevoﬂurane exposures(P＜0.05);
☆, signiﬁcant diﬀerences among the values in the PB-and N-groups after exposure to each anesthetic(P＜0.01);at H 0-H 12 and on Day 1-Day 7, see Fig. 1.
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 to be PAS(－)at H 0(Figs. 3b and 6). The PAS(－)
area increased beginning at H 3, reached a peak at H 12,
covering approximately 51.4 of the area from the CV to the PV(Figs. 3d and 6),which was a signiﬁcant increase compared with that at H 0, and decreased from Day 1,
returning to normal by Day 7 (Fig. 6). After a 2 h sevoﬂurane exposure in 10  oxygen, the PAS(－)area was observed to cover approximately 33.8  of the area from the CV to the PV at H 0(Figs. 3f and 6). Slightly increasing beginning at H 3, the PAS(－)area reached a peak at H 12, covering approximately 36.8  of the area from the CV to the PV(Figs. 3 h and 6), but it did not change signiﬁcantly compared with that of H 0 and decreased from Day 1, then returning to normal by Day 3(Fig. 6). In the PAS(－)area at H 6 after exposure to isoﬂurane or sevoﬂurane, signs of cell-swelling, pyknosis,
and fusion began to appear with these degenerative changes reaching a peak at H 12. From H 6 to H 12 after the sevoﬂurane exposure, the size of the PAS(－)area was signiﬁcantly smaller than that after isoﬂurane expo-
sure(P＜0.01)(Figs. 3c, d, g, h, and Fig. 6).
By MGP-staining it was found that distribution of rRNA granules began to disappear from 2-3 layers in the PAS(－)cells around the CV at H 3. During the period from H 6 to Day 3(isoﬂurane), and from H6 to Day 2
(sevoﬂurane), rRNA granules completely disappeared in the PAS(－)cells(Figs. 4c, d and Figs. 4 g, h), then returned to normal levels by Day 7(isoﬂurane)and Day 3(sevoﬂurane)(Fig. 6).
By H-E staining, the image was not morphologically diﬀerent from that of the control group in the PAS(＋)
area;cells in the PAS(－) area, however, were homogeneously stained with eosin from H 6 to Day 3
(isoﬂurane)and from H 6 to Day 2(sevoﬂurane)(Figs.
5c, d, g, and h), then returned to normal by Day 7
(isoﬂurane)and Day 3(sevoﬂurane). From H 6 to Day 1,
cells in the PAS(－) area were swollen with signs of fusion, vacuoles, pyknosis, and denucleation(Figs. 5d and h). At H 6, the inﬁltrated cells began to disperse in the PAS(－)area, and at H 12 many inﬁltration cells were visible(Figs. 5c, d, g, and h).
In the N-group, no changes were seen in the liver
 
Fig.6  Time-course changes in the area from the CV to the PV where the liver cells have become PAS(－)after isoﬂurane or sevoﬂurane exposure in the PB-and N-groups under 10%oxygen. Each value was obtained from the mean±SD of 25 values of each sample. Each sample value(y)is the percentage of the PAS(－)(b)to the length from the CV to the PV(a):y＝ b/a×100.●, isoﬂurane exposure in the BP-group;
■, sevoﬂurane exposure in the PB-group;◯, isoﬂurane exposure in the N-group;□, sevoﬂurane exposure in the N-group;★, signiﬁcantly larger or smaller than that at H 0(P＜0.01);☆, signiﬁcant diﬀerences among the values in the PB-and N-groups(P＜0.01);＊, signiﬁcant diﬀerences among the values after isoﬂurane and sevoﬂurane exposures(P＜0.01);at H 0-H12 and on Day 1-Day 7. In the N-group, PAS staining area signiﬁcantly decreased until H 6 after sevoﬂurane(□)or isoﬂurane(◯)exposure under 10% oxygen, and recovered to the normal level at H 12. H 0-12 and D 1-7, see Fig.1; PB-and N-group, see Fig.1; PAS(－), see Fig.4.
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tissues after a 2-h exposure to 10 oxygen alone. In the PB-group, however, PAS(－)cells appeared in zone 3 at H 0 after such exposure. In this PAS(－)area, the cells were slightly swollen, rRNA granules appeared in the cells at H 6, and vacuolated cells appeared at H 12,while rRNA granules had completely disappeared at H 12, but the tissue recovered to its normal hepatolobular structure on Day 2. Signiﬁcant diﬀerences were found in the size of the PAS(－)area at each collection time between the PB-and the N-groups from H 3 to Day 2 after each anesthetic exposure(Fig. 6).
To summarize Figs. 2 and 6, the PAS(－) area covered approximately 36.5  and 33.8  of the isoﬂurane-and sevoﬂurane-exposed livers, respectively,
from the CV to the PV at H 0. At H 6, the PAS(－)
area increased to approximately 47.6 (isoﬂurane)and 35.3 (sevoﬂurane)of the livers from the CV to the PV,
respectively, and rRNA in the cells disappeared from the PAS(－) area. From this time forward, AST levels,
which had been 46 U in the control, began to signiﬁcantly increase to approximately 91.6 U (isoﬂurane) and 84.4 U(sevoﬂurane), respectively. After the PAS(－)area and AST levels in the blood continued to increase until H 12,
both began to decreased and recovered to the control levels on Day 3.
Inﬁltrated cells began to appear in the PAS(－)area in the PB-group from H 6 after both anesthetic exposures and were cross-reacted with ED 1, which indicated that they were macrophages. The reaction of the BrdU- or ssDNA-intake was not observed until Day 7, indicating that neither hepatocellular proliferation nor apoptosis appeared in response to either isoﬂurane or sevoﬂurane exposure(Figs. 7a-j).
Discussion
 
All inhalation anesthetics have been reported to induce hepatic injury after anesthesia in rare cases［1, 2, 7-13］,
but a clear understanding of the process of anesthetic-
induced hepatic injury(necrosis)remains elusive. There have been some reports describing histochemical and immunohistochemical studies of the process of hepatic injury after halothane exposure to rats［14-16］.
In the present study, 1.5  isoﬂurane or 2.0 sevoﬂurane (approximately 1 MAC)was used for the exposure so that rats could inhale the greatest amount of anesthetics while still breathing naturally. A 2 h exposure
 
time was adopted because more than 1.5 h is needed to obtain a constant anesthetic concentration according to a report by Hirai［21］.
Glycogen and rRNA granules, in the PAS(－)area intracellularly disappear at H 0 and H 6, respectively, and at H 6, AST levels in the blood rose after exposure to each anesthetic. There were 2 patterns of development of the PAS(－)area after anesthetic exposure as follows:
the size of the PAS(－) area exposed to isoﬂurane continued to increase signiﬁcantly until H 12, while the area exposed to sevoﬂurane remained almost the same size as that at H 0 until H 12. At H 12, the PAS(－)
area had spread the most in cells exposed to the anes-
thetics in the order of isoﬂurane＞sevoﬂurane, which is a new ﬁnding in the study of isoﬂurane-and sevoﬂurane-
associated hepatic injury.
In the N-group, the PAS staining temporarily de-
creased after anesthetic exposure, but the cells in the PAS-decreased area did not become necrotic. In the PB-group, however, PB administration increased the metabolic activity and oxygen demand in the hepatocytes
［22］. Only under this accelerated metabolic state, the hepatocytes in the PAS(－)area degenerated to a necrotic state in response to anesthetic exposure in hypoxia. The cells negatively reacted to PAS from the early stage,
rRNA disappeared in the PAS(－)area, and inﬁltrated cells were mostly macrophages. A decrease in systemic as well as hepatic circulation was also previously described to have occurred in animals exposed to anesthetics in hypoxia［14, 21-23］. It is thought that the decreased supply of oxygen to the liver was further induced by oxygen concentrations reaching levels less than 10  in the current study. From these results, it is suggested that severe hypoxia is one of the factors causing necrotic degeneration in hepatocytes.
The appearance of a PAS(－)area and the disappear-
ance of rRNA granules in the PAS(－) area after isoﬂurane or sevoﬂurane exposure under 10  oxygen may be attributed to the inhibition of synthesis from DNA to mRNA preventing various syntheses, causing a part of the PAS(－)area to become necrotic. It is not yet clear whether the hepatic injury observed in this model is related to not only hypoxia but also to some active intermediates of anesthetics (which have not yet been speciﬁed). This theory is consistent with the reports of Shingu et al.［24, 25］, who observed an induction of liver injury in rats exposed to halothane or isoﬂurane in less than 10  oxygen and in less than 10  oxygen
 
9 Hepatic Injury by Inhalation Anesthesia February 2003
9
Honda et al.: Differential, histochemical and immunohistochemical changes
Produced by The Berkeley Electronic Press, 2003
10
Acta Medica Okayama, Vol. 57 [2003], Iss. 1, Art. 1
http://escholarship.lib.okayama-u.ac.jp/amo/vol57/iss1/1
 
alone.
Knights et al.［26］have reported the occurrence of mitosis in the liver at H 48 after halothane exposure, but in the study of BrdU-intake until Day 7 showed no hepatocellular regeneration after isoﬂurane or sevoﬂurane exposure. The reason why Knights et al. noted mitosis may be because they used a milder oxygen condition
(14  oxygen concentration) for halothane exposure compared with our severe condition(10 oxygen concen-
tration, with and without anesthetics).
According to Kerr［27］, necrosis occurs when hypoxia is severe, whereas apoptosis occurs when hypox-
ia is mild. In the current study, apoptosis was not observed from H 0 to Day 7 after isoﬂurane or sevoﬂurane exposure when we stained liver sections using anti-ssDNA rabbit polyclonal antibody. Our conditions,
however, may have been too severe to permit apoptosis.
The current study was carried out by the same method to compare that of the halothane. In rats exposed to halothane in the PB-group, the PAS(－)area covered approximately 56.3  of the area from the CV to the PV in the lobule at H 0, remaining almost the same size until Day 1, then decreasing. After halothane exposure, large vacuoles appeared in the boundary between the PAS(－)
area in the CV area where the cells had become necrotic and the PAS(＋)area in the PV area. At H12, AST values in the sera exposed to halothane were approximate-
ly 230 U.
Based on these results, the area where hepatocytes turned to PAS(－)in response to anesthetic exposure is considered to show the grade of hepatic injury. The grades of both isoﬂurane-and sevoﬂurane-induced hepatic injuries were found to be much lower than that of haloth-
ane, and that of isoﬂurane was greater than that of sevoﬂurane, which is consistent with the data of Yamasaki et al.［16］. If the results of the studies of the hepatic circulation in dogs made by Frink et al.［14］and Hirai［21］may be applied to the studies on rats, the PAS(－)areas in rat hepatocytes in the current study are likely related to the oxygen supply to the liver. In our results, however, it remains unclear whether appearance of the PAS(－)area and the disappearance of the rRNA are caused by the exposure to these anesthetics or by some other factors. In the N-group, hepatocyte changes are considered to be reversible after each anesthetic exposure in 10  oxygen.
As Rozga et al.［28］have described, the recovery from inhalation anesthetic-related necrosis in the CV area
 
might be due to the necrosis being compressed by and ﬁlled with hepatocytes located more peripherally in the lobule than in the necrotic area. As hepatocytes approach the central zone of the liver lobule, neighboring hepatic cell cords move closer to each other, becoming densely packed and compressed, and ﬁnally occluded the inter-
posed sinusoidal lumen. The liver reconstruction process observed in the current study appears to be the same as that reported in their study. The authors speculate that in the necrotic area,macrophages appeared from H 6 to Day 2, although neither apoptosis nor proliferation was observed in hepatocytes after isoﬂurane or sevoﬂurane exposure, and that the hepatolobular structure was recovered due to the rearrangement of the remaining hepatocytes in the PV area along the hepatic cell cords.
In conclusion, glycogen at H 0 and rRNA at H 6 disappeared from zone 3, and AST levels in the blood rose at H 6 after isoﬂurane or sevoﬂurane exposure under 10  oxygen in the PB-group, causing an inhibition of mRNA synthesis and a development of necrosis in the hepatocytes around the CV. There were two patterns of development of the PAS(－) area after isoﬂurane or sevoﬂurane exposure:the size of the PAS(－) area exposed to isoﬂurane kept increasing until Day 1, while that exposed to sevoﬂurane remained almost the same size until H 12 after the exposure. The grade of hepatic injury induced by isoﬂurane exposure was higher than that induced by sevoﬂurane.
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